Significant Research Findings
Significant ME/CFS Research
Significant Retroviral Findings Related to ME/CFS:
  • 2010 FDA and NIH – Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors – 86.5% of ME/CFS patients and 6.8% of blood donors
  • 2010 Norwegian Study – XMRV retrovirus found in 62% of ME patients tested in Norway
  • 2009 WPI Study – Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome – 67% of ME/CFS patients and 3.7% of healthy controls
Other Retroviral Work:
  • 2011 Emery University – Infection, viral dissemination and antibody responses of Rhesus macaques exposed to the human gammaretrovirus XMRV
  • 2010 Madrid, Spain – Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome
  • 2010 Frontiers of Virology: On the origin of XMRV
  • 2010 NIH –The mouse “xenotropic” gammaretroviruses and their XPR1 receptor
  • 2010 University of Utah – Patent application for a diagnostic test mentions finding XMRV in numerous cancers, including breast cancer tumors.
  • 2010 Emory University – Infected macaques had XMRV in their spleens, lymph nodes, gastrointestinal tract, lungs, liver, vaginal tissue and urinary tract.
  • 2010 German Study – XMRV-Related Gammaretrovirus in Respiratory Tract
  • 2010 WPI Study – XMRV: Virological, immunological and clinical correlations in patients with chronic lymphocytic leukemia and mantle cell lymphoma
  • 2009 Japanese Study – The Prevalence of XMRV in Healthy Blood Donors in Japan – 1.7% of blood donors
  • 2006 Cleveland Clinic – Identification of a novel gammaretrovirus in prostate tumors – 40% of patients with aggressive prostate cancer have XMRV
First International Conference on XMRV